medullary thyroid cancer

You have access
Preliminary clinical experience of cholecystokinin-2 receptor PET/CT imaging using the ⁶⁸Ga-labeled minigastrin analog DOTA-MGS5 in patients with medullary thyroid cancer
Elisabeth von Guggenberg, Christian Uprimny, Maximilian Klingler, Boris Warwitz, Anna Sviridenko, Steffen Bayerschmidt, Gianpaolo Di Santo and Irene J. Virgolini

Journal of Nuclear Medicine January 19, 2023, jnumed.122.264977; DOI: https://doi.org/10.2967/jnumed.122.264977
You have access
Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog ¹⁷⁷Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?
Alexander W. Sauter, Rosalba Mansi, Ulrich Hassiepen, Lionel Muller, Tania Panigada, Stefan Wiehr, Anna-Maria Wild, Susanne Geistlich, Martin Béhé, Christof Rottenburger, Damian Wild and Melpomeni Fani

Journal of Nuclear Medicine March 1, 2019, 60 (3) 393-399; DOI: https://doi.org/10.2967/jnumed.118.207845

Main menu